R&D channel feed – Endpoints News

R&D channel feed

A teenager faced constant seizures. Could a drug developed just for him stop them?

10 months ago

Roche details early obesity data from GLP-1/GIP agonist, plans for Phase 2 study this year

10 months ago

Revolution Medicines' RAS inhibitor shows promise in early-stage pancreatic cancer trial

10 months ago

Updated: Lexeo Therapeutics' gene therapy shows potential for Friedreich's ataxia cardiomyopathy with early data

10 months ago

Lilly says lupus drug dropped from pipeline failed to show efficacy

10 months ago

Indivior axes schizophrenia drug and shrinks revenue guidance

10 months ago

Immutep’s LAG-3 drug scores in Phase 2b head and neck cancer test

10 months ago

Pfizer presses forward with once-daily GLP-1 pill in long-awaited move

10 months ago

Ipsen takes on another ADC, this time from a China-based biotech

10 months ago

AbbVie CSO Tom Hudson to retire, replaced by medical chief

10 months ago

In less-studied female mice, scientists find hormone that could lead to new bone disease treatments

10 months ago

Amgen shelves early-stage bispecific T cell engager

10 months ago

Six big R&D questions for Pfizer as science chief Dolsten exits

10 months ago

UniQure trumpets mid-stage data for Huntington's disease gene therapy

10 months ago

Chinese drugmakers still lag in R&D depth despite outpacing Europeans in new launches

10 months ago

Lilly bests Novo Nordisk in observational study of GLP-1 drugs

10 months ago

Infections are major cause of non-relapse deaths after CAR-T cell therapy, study shows

10 months ago

HilleVax's stock tumbles after Phase 2b norovirus vaccine fails in infants

10 months ago

Ideaya showcases proof-of-concept data in a boost to synthetic lethality play

10 months ago

With cash expected to run dry, Inventiva ramps up search for funding

10 months ago

Roche’s TIGIT drug tiragolumab flunks another Phase 3 lung cancer test

10 months ago

Apollomics plans to lay off staff, narrow focus for lung cancer trial

10 months ago

Moderna wins $176M BARDA award to finance bird flu work

10 months ago

Following a pivotal trial fail and layoffs, Ovid finds itself in a familiar spot

10 months ago

First page Previous page 34 35 363738 39 40 Next page Last page